Media specialist


Cardiol Therapeutics Announces Acceleration of Expiry Date of Warrants Issued on June 4, 2020

Oakville, Ontario--(Newsfile Corp. - September 10, 2021) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage biotechnology company focused on developing innovative anti-inflammatory therapies for the treatment of cardiovascular disease, announces the acceleration of the expiry date of all outstanding common share purchase warrants (the "Warrants") of the Company that were issued on June 4, 2020, pursuant to a Canadian public offering (the "Offering"). The Warrants bear the CUSIP Number: 14161Y127 and the ISIN: CA14161Y1271. The Warrants are not listed for trading on the TSX or NASDAQ.

Under the terms of the Warrant Indenture dated as of June 4, 2020, as supplemented (the "Warrant Indenture"), each Warrant entitled the holder thereof to acquire one Common Share (a "Warrant Share") at a price of $3.25 per Warrant Share for a period of 24 months from issuance, subject to a Warrant acceleration right exercisable by the Company if the daily volume weighted average trading price of the Common Shares on the Toronto Stock Exchange (the "TSX") is at least $4.50 per Common Share for a period of ten consecutive trading days ("Acceleration Right").

The Company confirms that as of the close of markets on September 10, 2021, the Company is now in a position to exercise its Acceleration Right. In accordance with the terms of the Warrant Indenture, this news release constitutes notice of acceleration (the "Acceleration Notice") to Warrant holders of the exercise of the Acceleration Right. Accordingly, the Company confirms that the Warrants are now set to expire at 4:00 p.m. (Eastern Standard Time) on Tuesday, October 12, 2021, being the next business day after the 30th day following the delivery of the Acceleration Notice (the "Early Expiry Date"). Any Warrants remaining unexercised after the Early Expiry Date will be automatically cancelled for no consideration.

As of the close of market on September 10, 2021, a total of 744,156 Warrants has yet to be exercised under the Warrant Indenture.

Holders may exercise the Warrants before 4:00 p.m. (Eastern Standard Time) on Tuesday, October 12, 2021 (but not after), by completing the process and the documentation set out in the certificates representing the Warrants and the Warrant Indenture before that time. The contact details for the Warrant Agent are Computershare Trust Company of Canada, 3rd Floor, 510 Burrard Street, Vancouver, BC V6C 3B9, Attention: General Manager, Corporate Trust.

About Cardiol Therapeutics

Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) is a clinical-stage biotechnology company focused on the research and clinical development of innovative anti-inflammatory therapies for the treatment of cardiovascular disease ("CVD"). The Company's lead product, CardiolRx™, is a pharmaceutically produced oral cannabidiol formulation that is being investigated in a Phase II/III outcomes study (the LANCER trial). The LANCER trial is designed to evaluate the efficacy and safety of CardiolRx as a cardioprotective therapy to reduce mortality and major cardiovascular events in patients hospitalized with COVID-19 who have a prior history of, or risk factors for, CVD, and to investigate the influence CardiolRx has on key markers of inflammatory heart disease.

Cardiol has also received clearance from the FDA for its investigational new drug ("IND") application for a Phase II international trial that will investigate the anti-inflammatory and anti- fibrotic properties of CardiolRx in patients with acute myocarditis, which remains the most common cause of sudden cardiac death in people under 35 years of age. In addition, Cardiol is developing a subcutaneous formulation of CardiolRx and other anti-inflammatory therapies for the treatment of chronic heart failure - a leading cause of death and hospitalization in North America, with associated annual healthcare costs in the U.S. alone exceeding $30 billion.

For more information about Cardiol Therapeutics, please visit

Cautionary statement regarding forward-looking information:

This news release contains "forward-looking information" within the meaning of applicable securities laws. All statements, other than statements of historical fact, that address activities, events, or developments that Cardiol believes, expects, or anticipates will, may, could, or might occur in the future are "forward-looking information". Forward looking information contained herein may include, but is not limited to, statements relating to the Company's focus on developing innovative anti-inflammatory therapies for the treatment of CVD. Forward-looking information contained herein reflects the current expectations or beliefs of Cardiol based on information currently available to it and is based on certain assumptions, and is subject to a variety of known and unknown risks and uncertainties and other factors that could cause the actual events or results to differ materially from any future results, performance, or achievements expressed or implied by the forward-looking information, and are not (and should not be considered to be) guarantees of future performance. These risks and uncertainties and other factors include the risks and uncertainties referred to in the Company's Annual Information Form dated March 31, 2021, as well as the risks and uncertainties associated with product commercialization and clinical studies. These assumptions, risks, uncertainties, and other factors should be considered carefully, and investors should not place undue reliance on the forward-looking information. Any forward-looking information speaks only as of the date on which it is made and, except as may be required by applicable securities laws, Cardiol disclaims any intent or obligation to update or revise such forward-looking information, whether as a result of new information, future events, or results, or otherwise.

For further information, please contact:

David Elsley, President & CEO +1-289-910-0850

Trevor Burns, Investor Relations +1-289-910-0855

Corporate Logo

To view the source version of this press release, please visit


11 months ago
Chris Ryan PhD., NYT Best Selling Author & Featured TED Talk Speaker To Appear At "Meet Delic": The World's Premiere Psychedelic & Wellness Event

Chris Ryan PhD., New York Times Best Selling Author, and Featured TED Talk Speaker To Appear At Meet Delic: The World's Premiere Psychedelic and Wellness Event

Meet Delic, the revolutionary, two-day immersive edutainment experience for the world's leading psychedelic and wellness thought and business leaders will take place at AREA15 in Las Vegas, Nevada November 6 – 7, 2021

VANCOUVER, BC Sept. 9, 2021 /PRNewswire/ - Delic Holdings Corp (" Delic " or the "Company") (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), the leading psychedelic wellness platform, today announced that Chris Ryan Ph.D. will serve as one of the headline speakers at Meet Delic on November 7 . Ryan is the New York Times best-selling co-author of, Sex at Dawn: How We Mate, Why We Stray, and What it Means for Modern Relationships and hosts the podcast, Tangentially Speaking His work has been translated into over twenty languages and he appears as a frequent guest on major broadcast networks. Chris's latest book, Civilized to Death: The Price of Progress questions whether "civilization" has been a net benefit to our species.

Meet Delic Logo (CNW Group/Delic Holdings Inc.)

Meet Delic is the largest and most comprehensive event to learn about the intersection of psychedelics, wellness, and business with like minded visionaries. Ryan's keynote, 'Psychedelics and the Search for Truth' will explore the emerging potential for psychedelics to reshape the modern world.

"I'm excited and honored to be joining some of the world's leading researchers, clinicians, and philosophers working with psychedelics at MeetDelic," states Ryan. "This promises to be an unforgettable event."

Meet Delic is committed to bringing awareness of the science-backed benefits of psychedelics and business opportunities to the mainstream and larger global community by reframing the psychedelic conversation. The experiential event will feature dancers, music, 3D-mapping, visual artists, new technologies and research, thought-provoking presentations and one of the world's largest psychedelic business expo.

"It is an honor to have Chris Ryan speak at our conference and bring his unique perspectives on health, life and culture to our attendees," said Delic co-founder, Jackee Stang . "He is an experienced psychonaut, successful entrepreneur and a true renaissance man and his presence at the event will be invaluable."

The twenty hours of panels and keynotes will include an array of topics such as " Why Are Psychedelics Medicine? ", " How Big Money is (Already) Playing Psychedelics," PTSD Reset and Recovery ," " Psychedelics & Addiction: an Intimate Discussion on Recovery in a Modern World, " " Ketamine Clinics Today, Psilocybin and MDMA Therapy Tomorrow ," " Microdosing ," " Psychedelic Activism ," " Aphrodisiacs and Psychedelics: A History of Medicine for Love ", " How Psychedelics Can be Effectively Used for Physical Optimization ," and " Drug Use for Grown-Ups ." Musical and entertainment acts are scheduled both evenings following the panels and expo.

Tickets are now available for the two-day experience. For more information please visit, Follow us on @meetdelic on Instagram, Twitter and Facebook Tickets available now .

Meet Delic is a subsidiary of Delic, which is focused on bringing psychedelic wellness to the mainstream. The company does this through an umbrella of related owned and operated businesses to support scaling the impact and reach of treatment, including 1) trusted media and e-commerce platforms and in-person events like Meet Delic to market the services directly to patients and consumers and gain data, 2) a licensed lab to develop IP, R&D and innovative high quality and safe product lines and 3) the largest and most accessible network of physical clinics to administer effective treatments.

About Meet Delic
Meet Delic is the world's premier psychedelic and wellness edutainment event catering to both curious newcomers, businesses and thought leaders. Held in AREA15, an immersive and experiential entertainment complex in the heart of Las Vegas , the exciting two-day event features industry entrepreneurs, consumers, psychonauts and leading voices in research and science. Meet Delic is the largest and most comprehensive event to learn about the intersection of psychedelics, health and wellness and culture, how to start or grow your business, connect with likeminded visionaries, enjoy fun social activities, and experience the acceleration of this worldwide movement.

About Delic Corp
Delic is the leading psychedelic wellness platform, committed to bringing science-backed benefits to all and reframing the psychedelic conversation. The company owns and operates an umbrella of related businesses, including trusted media and e-commerce platforms like Reality Sandwich and Delic Radio Delic Labs the only licensed entity by Health Canada to exclusively focus on research and development of psilocybin vaporization technology, Meet Delic the premiere psychedelic wellness event, and Ketamine Infusion Centers one of the largest ketamine clinics in the country. Delic is backed by a team of industry and cannabis veterans and a diverse network, whose mission is to provide education, research, high-quality products, and treatment options to the masses.

The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release and does not accept responsibility for the adequacy or accuracy of this release.

Forward-Looking Information and Statements
This press release contains certain "forward-looking information" within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company's beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of Delic's control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or may contain statements that certain actions, events or results "may", "could", "would", "might" or "will be taken", "will continue", "will occur" or "will be achieved".

By identifying such information and statements in this manner, Delic is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of Delic to be materially different from those expressed or implied by such information and statements. In addition, in connection with the forward-looking information and forward-looking statements contained in this press release, Delic has made certain assumptions.

Should one or more of these risks, uncertainties or other factors materialize, or should assumptions underlying the forward-looking information or statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected.

Although Delic believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and Delic does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws. All subsequent written and oral forward- looking information and statements attributable to Delic or persons acting on its behalf is expressly qualified in its entirety by this notice.


Cision View original content to download multimedia:

SOURCE Delic Holdings Inc.


11 months ago
Wall Street Reporter: "CEOs of lululemon, ESE Entertainment, Lightspeed Commerce and AI/ML Innovations Discuss New Megatrends..."

CEOs of lululemon, ESE Entertainment, Lightspeed Commerce and AI/ML Innovations Discuss New Megatrends in E-Sports, HealthTech, E-Commerce, & Wellness Powering Revenue Growth

NEW YORK, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at: lululemon athletica (NASDAQ: LULU), AI/ML Innovations (OTC: AIMLF) (CSE: AIML), ESE Entertainment (OTC: ENTEF) (TSX.V: ESE) and Lightspeed Commerce (NYSE: LSPD) (TSX: LSPD).

AI/ML Innovations (OTC: AIMLF) (CSE: AIML) Chairman, Tim Daniels: “Mental Health App Expands AI/ML Digital Health Ecosystem - Targeting Multi-Billion Dollar Market Opportunities”
NEXT SUPER STOCK conference presenter AI/ML Innovations (OTC: AIMLF) (CSE: AIML) is rapidly expanding its portfolio of HealthTech assets. AIMLF chairman Tim Daniels updated investors on the company’s latest digital healthcare growth initiatives, which now includes Tech2Health, a European mental health app innovator. Tech2Health is positioned for explosive revenue growth as European healthcare mandates now provide about 2,500 Euro per patient annually for mental wellness. Tech2Health has just signed with a French multinational manufacturer, to provide mental wellness support to their 170,000 employees globally, and additional Enterprise contracts are in the pipeline.
Watch AI/ML Innovations (OTC: AIMLF) (CSE: AIML) NEXT SUPER STOCK Video:

AIMLF Chairman Tim Daniels shared with investors how AIMLF is expanding its global digital healthcare footprint with synergistic acquisitions of innovative HealthTech companies. Tim also updated investors on progress at AIMLF’s HealthGauge platform which uses AI and machine learning for applications ranging from remote patient monitoring, to fitness/health tracking and more. AIMLF focus is on scaling revenue growth, by offering its services to enterprise and consumers via a SaaS recurring revenue subscription model. Tim Daniels also updated investors on AIML’s growing pipeline of M&A opportunities in the HealthTech space, which could have a positive impact on maximizing shareholder value in coming months.

Watch AI/ML Innovations (OTC: AIMLF) (CSE: AIML) NEXT SUPER STOCK Video:

lululemon athletica (NASDAQ: LULU) CEO Calvin McDonald: “We’re Still In Early Stages of Growth in Product Innovation”

“...We are in the early stages of growth within our product innovation pillar and we have ample ways to expand our key categories of Run, Train, Yoga and On The Move. Over the course of 2021, you will see us scaling the Science of Feel to bring more technical innovations across our major categories.

“...Since the acquisition of MIRROR five months ago, we have made steady progress on the integration and we are pleased with the brand's performance in Q3 and with how the holiday season has begun. We continue to expect MIRROR to generate in excess of $150 million in revenue in 2020. Over the course of the third quarter, we began to leverage the lululemon ecosystem to raise awareness for MIRROR. We launched a dedicated MIRROR tab in our US ecom site, including a hyperlink for guests to complete a purchase transaction, and we have included MIRROR in our e-mail marketing campaigns. In November, we created shop-in-shops in 18 of our US locations to test and learn how to refine our in-store selling experience and we plan to expand this to several hundred stores next year….Our guests are blown away by the sleek design and functionality of MIRROR that is as innovative and unique as our own products. We are just at the beginning of our journey with MIRROR and we are thrilled with the current momentum and excited with what this can mean for next year and beyond….”

lululemon athletica (NASDAQ: LULU) Earnings Highlights:

ESE Entertainment (TSX.V: ESE) (OTC: ENTEF) CEO Konrad Wasiela: “On Track for $100 Million E-Sports Revenues”
ESE Entertainment (TSX.V: ESE) (OTC: ENTEF) CEO Konrad Wasiela, a featured presenter at Wall Street Reporter’s NEXT SUPER STOCK investors livestream conference, recently updated investors on his goal of building ESE into a billion dollar global enterprise. Wasiela shared that “ESE now has a growing M&A pipeline with over $100 million annual revenues” and expected to close a significant number of these potential transactions in the coming months. ENTEF just announced the acquisition of e-sports company Auto Simulation Limited T/A Digital Motorsports, an Ireland-based provider of advanced simulation racing (“sim racing”) infrastructure, technology, and support. Sim racing is one of the hottest growth categories in the multi-billion dollar global e-sports market.

ENTEF recently closed the acquisition of e-sports and gaming infrastructure company, WPG. In 2020, WPG’s assets generated revenue in excess of C$14,000,000. This transaction is anticipated to make ENTEF one of the largest esports infrastructure companies in the world, bridging esports companies with their fans and customers.

Watch ESE (OTC: ENTEF) (TSX.V: ESE) Next Super Stock livestream video:

In his interview with Wall Street Reporter, ESE CEO Konrad Wasiela, says the company is now ready to scale - expanding its global footprint, with new partnerships with global brands like Porsche, driving revenue growth with aggressive focus on top line sales and margin expansion, and M&A opportunities. ESE is now rapidly expanding, with multiple revenue streams including, E-Sports infrastructure software powering global tournaments, exclusive digital media distribution, broadcast rights, and owning world-class leagues and teams, including its K1CK global E-Sports franchise.
Watch ESE (OTC: ENTEF) (TSX.V: ESE) Next Super Stock livestream video:

Lightspeed Commerce (NYSE: LSPD) (TSX: LSPD) CEO, Dax Dasilva: “Lightspeed: a True One-Stop Commerce Platform”
“...As economies reopen around the world and new business creation accelerates, we believe Lightspeed's one-stop commerce platform remains a crucial lifeline for independent businesses. Our goal is to help them simplify their operations, provide them unparalleled opportunities to scale and equip them to deliver exceptional customer experiences...We continue to see great opportunities. Payments adoption can go higher. Delivering a unified solution in retail and hospitality should allow for greater software adoption amongst our customer base. Our capital business is still very much in its infancy and the potential from the B2B side with NuORDER and our supplier network has not yet even begun to impact our top line...There remains a lot of heavy lifting and long hours ahead but the potential for Lightspeed as a true one-stop commerce platform has never been greater and the probability of success has in my mind never been higher.”
Lightspeed Commerce (NYSE: LSPD) Earnings Highlights:


Wall Street Reporter (Est. 1843) is the leading financial news provider, focused on giving investors direct access to CEO's of promising, publicly-traded companies, and market experts. . Nothing in this news summary shall be construed as investment advice. Quotes/content may be edited for brevity and context.Full disclaimer, and relevant SEC 17B disclosures here:

About Wall Street Reporter’s Next Super Stock conference:

Wall Street Reporter's NEXT SUPER STOCK Live! conference is dedicated to featuring select companies that have near-term catalysts in place which can drive transformational growth (and stock appreciation) in the months ahead. Click here to join next livestream event:



(212) 871-2057 ext 7


11 months ago
Marble Licenses Its Proprietary Marble Connect API with Konect Ai

VANCOUVER, British Columbia, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Marble Financial Inc. (CSE: MRBL; OTC: MRBLF; FSE:2V0) ("Marble" or the "Company"), an AI-driven financial technology company that educates and helps consumers better understand and manage their current cash flow and credit towards a better financial future, is pleased to announce a licensing agreement with Konect Ai to supply over 50 automotive dealerships and their customers direct access through Marble Connect to Marble’s proprietary financial wellness platform, MyMarble.

Connect is Marble’s new and innovative B2B white-label integration product that provides a customized, AI-driven personal finance solution that connects the MyMarble platform into the partner’s customer journey and product offering. It offers consumers their free credit score, financial health report, real-time plans, and recommendations to make a positive impact on their overall finances to gain access to their company's financial products and services. Konect Ai, a leader in automotive artificial intelligence lead scoring, integrates with over 50 automotive businesses across Canada to help validate and engage over 10,000 monthly customers looking to purchase a new or used vehicle. This is achieved through utilizing its technology to streamline and automate the sales process to maximize conversions and long-term customer advocacy.

Statistics Canada recently reported a 25% increase in new car sales for June, 2021 , as well as data from Transunion showing that consumer credit inquiries rose over 5% . These positive numbers present a powerful growth projector for both Marble and Konect Ai as the demand for detailed insight on buying power and creditworthiness is more than ever critical during the customer journey.

Marble Connect will automatically enroll all 10,000+ monthly customers coming through Konect Ai integrations into MyMarble to provide its automotive partners with a comprehensive financial overview and likelihood of approval using its proprietary risk scoring and analysis. Marble Connect will also aid in establishing long-term brand loyalty by empowering customers through MyMarble’s programs, guidance, and tools to achieve the credit score, debt, and budget targets required for approval or improved interest rates in the future.

“Our latest partnership with Konect Ai is going to completely transform how automotive businesses manage and nurture their customers to achieve their goal of car ownership through a personalized and premium experience, no matter their financial history,” says Doug Tanner, Marble’s VP of Business and Corporate Development. “We are extremely excited to be introducing Marble Connect with a fellow technology-focused leader and as we’ve witnessed at Marble the utilization of artificial intelligence is the most effective way to provide a quality and effective solution for our partners and customers, a goal that both Marble and Konect Ai aim to achieve, respectively.”

"At Konect Ai, we are now working with over 50 automotive partners that collectively generate hundreds of thousands of new customers every year. We've discovered that many of their customers need some form of guidance and assuredness when it comes to their overall financial health,” says Paul Lehal, Konect Ai CTO. “Our latest engagement with Marble is extremely exciting for us. It now empowers our partners to continue to leverage Konect Ai's industry-leading technology but now with the added value of real-time financial tools and education to help their clients improve their financial standing.”

Under the terms of the agreement, Marble will receive monthly fees from Konect Ai for new customers that engage with the cobranded API solution through its dealership network.

About Konect Ai. Over the past 10 years, we have developed our Konect Ai software and grown our team. Building something as a team teaches your employees to work together, collaborate, share, trust, and grow together. To this day we have put together the best team of custom coders, graphic designers, data collectors, management, content writers and content creators. We have had the time to study the markets and perfect the lead generation business. The software we have created has not only provided our clients with success, but it has also brought success to our incredible team.

For more information about Konect Ai please visit:

About Marble Financial Inc. (CSE: MRBL; OTC: MRBLF; FSE:2V0) Marbles’ proprietary MyMarble platform utilizes the power of machine learning, data science, and artificial intelligence, in leveraging its proven data-driven strategies through technology solutions Inverite, Score-Up, Fast Track, Maestro and Connect to engage in and navigate a clear path towards financial wellbeing and a meaningful credit score, since 2016, Marble is proud to have empowered thousands of marginalized consumers to a positive financial future, and we continue to establish ourselves as leaders in financial wellness through the licensing of our proprietary products on the MyMarble Platform.

For further information about Marble Financial, please visit:

Mike Marrandino, Executive Chairman

T:(855) 661-2390 ext. 104 Email:

(1) Source:

(2) Source:


Caution Regarding Forward-Looking Information

This release contains forward-looking statements. Forward-looking statements, without limitation, may contain the words beliefs, expects, anticipates, estimates, intends, plans, or similar expressions. Forward-looking statements are not guaranteeing future performance. They involve risks, uncertainties and assumptions and actual results could differ materially from those anticipated. Forward looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. Except for historical facts, the statements in this news release, as well as oral statements or other written statements made or to be made by Marble, are forward-looking and involve risks and uncertainties. The forward-looking information included in this release is expressly qualified in its entirety by this cautionary statement. Accordingly, readers should not place undue reliance on forward-looking information. The Company undertakes no obligation to update these forward-looking statements, other than as required by applicable law.

Primary Logo



11 months ago
AI/ML’s Health Gauge Collaborates with Trinity Western University (“TWU”) to Validate the Use of the HG Solution for Performance Athletics Programs

TORONTO, ON / ACCESSWIRE / September 9, 2021 / AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIML)(FWB:42FB), a company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is pleased to announce that its majority-owned subsidiary, Health Gauge ("HG"), has undertaken a 12-month Pilot Project and collaboration with Trinity Western University ("TWU"). This collaboration will be spearheaded by Dr Anita Cote, a cardiovascular physiologist who holds a Canada Research Chair in Cardiovascular Adaptation to Exercise at TWU.

The purpose of this collaboration is to study the efficacy of health data aggregated via HG's remote monitoring solution. The data collected will help to define and establish a program to quantify how personal health monitoring solutions may improve performance specific to selected sports.

HG's goal is to validate the benefit of its solution as a productive tool to help improve performance of athletes, allowing HG to then capitalize on commercial opportunities within the lucrative high-performance athletic market.

As part of this collaboration, TWU will be supplied with 150 HG smartwatches for several CIS athletic focus groupings including men and women's Soccer, Hockey, Basketball, Volleyball, Track & Field, and Basketball.

A picture containing graphical user interfaceDescription automatically generated

About Health Gauge

Health Gauge's patent-pending solution is a personal health monitoring & management system, which combines the latest wearable health monitors with sophisticated artificial intelligence software tools and proprietary cloud computing software, to help caregivers, patients, and healthcare professionals access and utilize relevant data, resulting in better recovery outcomes and healthy living objectives through the ability to make immediate and better health choices.

Health Gauge is not a medical device and is not intended to diagnose, treat, cure, or prevent any disease. The Service is not meant as a substitute for or alternative to information from health care practitioners. If you have, or suspect you have, a medical condition, consult your doctor before using the Service, starting an exercise program, or changing your diet.

About AI/ML Innovations Inc.

AI/ML Innovations Inc. has realigned its business operations to capitalize on the burgeoning fields of artificial intelligence (AI) and machine learning (ML), with an initial investment focus on emerging digital health and wellbeing companies that leverage AI, ML, cloud computing and digital platforms to drive transformative healthcare management solutions and precision support delivery across the health continuum. Through strategic partnerships with Health Gauge (70% owned by AIML), Tech2Health and other planned accretive investments, the Company continues to capitalize on expanding growth areas, to the benefit of all the Company's stakeholders. AI/ML's shares are traded on the Canadian Securities Exchange under the symbol "AIML", the OTCQB Venture Market under "AIMLF", and the Frankfurt Stock Exchange under "42FB".

On behalf of the Board of Directors

Tim Daniels, Executive Chairman

For more information about AI/ML Innovations:

For detailed information please see AI/ML's website at or the Company's filed documents at

For further information: Blake Fallis at (778) 405-0882 or


Investor slidedeck:

Corporate video:

Official YouTube Channel:

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

Cautionary and Forward-Looking Statements

Certain information in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of the Company, including but not limited to, the uncertainty of competition by other industry players, the impact of general economic conditions, industry conditions, dependence upon regulatory approvals and the ability to raise additional capital as may be needed in the future. Readers are cautioned that the assumptions used in preparing such information, although considered reasonable at the time of preparation, may prove imprecise and undue reliance should not be placed on forward-looking statements. Forward-looking statements in this press release are expressly qualified by this cautionary statement.

The forward-looking statements in this press release are made as of the date of this press release, and the Company undertakes no obligations to update publicly or to revise any of the included forward-looking statements, whether because of new information, future events or otherwise, except as expressly required by applicable securities law.

SOURCE: AI/ML Innovations Inc.


11 months ago
Activity Points
Your Rating
Date Joined
Social Links
Private Message

Followed Members

Last Posted: